| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Ancillary Network | 19.0 | | | | | | | |
| Urgent and Primary Care | 10.0 | | | | | | | |
| Total revenues | 10.0 | 3.9 | 26.8 | 34.9 | 48.9 | 61.2 | 68.2 | 58.3 |
| Revenue growth | 156.6% | -85.4% | -23.4% | -28.6% | -20.1% | -10.3% | 17.0% | 148.2% |
| Cost of goods sold | 11.1 | 5.3 | 5.3 | 30.2 | 44.4 | 53.8 | 59.0 | 49.3 |
| Gross profit | -1.1 | -1.4 | 21.5 | 4.7 | 4.5 | 7.5 | 9.3 | 9.0 |
| Gross margin | -10.6% | -35.2% | 80.4% | 13.3% | 9.2% | 12.2% | 13.6% | 15.5% |
| Selling, general and administrative [+] | 6.8 | 3.9 | 2.4 | 6.8 | 6.0 | 6.2 | 7.4 | 5.1 |
| General and administrative | 6.8 | 3.9 | 2.4 | | | | | |
| Other operating expenses | 2.6 | 1.0 | 20.8 | 8.0 | 11.5 | | 0.6 | |
| EBITDA [+] | -10.5 | -5.7 | -1.6 | -10.2 | -12.9 | 1.3 | 1.9 | 3.9 |
| EBITDA growth | 84.9% | 243.8% | -83.9% | -20.8% | -1123.7% | -33.5% | -51.9% | -554.0% |
| EBITDA margin | -104.3% | -144.7% | -6.1% | -29.3% | -26.4% | 2.1% | 2.8% | 6.8% |
| Depreciation | 0.9 | 0.8 | 0.7 | 0.9 | 0.8 | 0.8 | 0.6 | 0.4 |
| EBITA | -11.4 | -6.5 | -2.3 | -11.1 | -13.7 | 0.5 | 1.3 | 3.5 |
| EBITA margin | -113.5% | -165.7% | -8.6% | -31.8% | -28.0% | 0.8% | 2.0% | 6.0% |
| Amortization of intangibles | 0.1 | 0.0 | 0.1 | | | | | |
| EBIT [+] | -11.5 | -6.5 | -2.4 | -11.1 | -13.7 | 0.5 | 1.3 | 3.5 |
| EBIT growth | 76.7% | 167.2% | -78.0% | -18.9% | -2876.9% | -63.0% | -62.2% | -394.6% |
| EBIT margin | -114.9% | -166.9% | -9.1% | -31.8% | -28.0% | 0.8% | 2.0% | 6.0% |
| Non-recurring items [+] | 1.8 | | | | 4.4 | | | |
| Asset impairment | 1.8 | | | | 4.4 | | | |
| Interest expense, net [+] | 0.4 | 0.1 | 0.0 | | | -0.1 | -0.1 | -0.2 |
| Interest expense | 0.4 | 0.1 | | | | | | |
| Interest income | | | 0.0 | | | 0.1 | 0.1 | 0.2 |
| Other income (expense), net [+] | 1.2 | -0.5 | -1.3 | 8.0 | 11.5 | | 0.3 | |
| Asset impairment charges | 0.7 | | | | | | | |
| Gain (loss) on sale of assets | | | 0.0 | | | | | |
| Gain (loss) on derivative instruments | 0.9 | -0.5 | | | | | | |
| Other | 0.8 | 0.6 | 0.0 | | | | | |
| Pre-tax income | -12.5 | -7.2 | -3.8 | -3.1 | -6.6 | 0.6 | 1.8 | 3.7 |
| Income taxes | 0.0 | 0.1 | 0.0 | 0.0 | 0.6 | 0.1 | -0.5 | 0.1 |
| Tax rate | | | | | | 18.6% | | 1.8% |
| Earnings from continuing ops | -11.8 | -7.7 | -3.8 | -3.1 | -7.2 | 0.5 | 2.3 | 3.6 |
| Earnings from discontinued ops | -0.8 | 0.5 | | | | | | |
| Net income | -12.6 | -7.2 | -3.8 | -3.1 | -7.2 | 0.5 | 2.3 | 3.6 |
| Net margin | -125.9% | -185.3% | -14.1% | -8.9% | -14.8% | 0.8% | 3.4% | 6.2% |
| |
| Basic EPS [+] | ($1.58) | ($1.20) | ($0.66) | ($0.54) | ($1.28) | $0.03 | $0.15 | $0.24 |
| Growth | 31.4% | 81.7% | 22.3% | -57.6% | -4448.0% | -80.4% | -37.8% | -527.7% |
| Diluted EPS [+] | ($1.57) | ($1.20) | ($0.66) | ($0.54) | ($1.28) | $0.03 | $0.13 | $0.21 |
| Growth | 30.5% | 81.7% | 22.3% | -57.6% | -4612.5% | -78.3% | -36.3% | -463.8% |
| |
| Shares outstanding (basic) [+] | 7.5 | 6.4 | 5.7 | 5.7 | 5.7 | 16.6 | 15.5 | 15.1 |
| Growth | 16.7% | 12.1% | 0.1% | 0.7% | -65.8% | 7.0% | 2.6% | 3.7% |
| Shares outstanding (diluted) [+] | 7.5 | 6.4 | 5.7 | 5.7 | 5.7 | 17.2 | 17.8 | 17.7 |
| Growth | 17.4% | 12.1% | 0.1% | 0.7% | -67.0% | -3.3% | 0.2% | 21.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |